University's school of medicine, Medical school in True Blue, Grenada

New York, June 18 Administering convalescent plasma from recovered Covid-19 patients can dramatically improve likelihood of survival among blood cancer patients hospitalised with the deadly virus, according to a study.The study led by researchers from the Washington University in the US indicates a 48 per cent reduced risk of death for Covid patients who had blood cancer and had received convalescent plasma compared to similar patients who did not receive this treatment.The survival benefit with convalescent plasma was even greater in patients who were admitted to the intensive care unit (60 per cent reduced risk of death) and those who needed mechanical ventilation (68 per cent reduced mortality)."These results suggest that convalescent plasma may not only help Covid-19 patients with blood cancers whose immune systems are compromised, it may also help patients with other illnesses who have weakened antibody responses to this virus or to the vaccines," said Jeffrey P. Henderson, Associate Professor of medicine and of molecular microbiology at the University's School of Medicine in St. Louis."The study also emphasises the value of an antibody therapy such as convalescent plasma as a virus-directed treatment option for hospitalised Covid-19 patients," Henderson added. The findings are published in the journal JAMA Oncology.The therapy involves transfusing plasma the pale yellow liquid in blood that is rich in antibodies from people who have recovered from Covid-19 into patients who have leukemia, lymphoma or other blood cancers and are hospitalised with the viral infection. The goal is to accelerate their disease-fighting response. Cancer patients may be at a higher risk of death related to Covid-19 because of their weakened immune systems.The team studied 143 patients who received convalescent plasma, and 823 who did not. Of the 338 patients admitted to ICUs because of severe Covid-19 symptoms, such as difficulty breathing or cardiac distress, those who received the treatment were more than twice as likely to survive.In March 2020, the US Food and Drug Administration approved convalescent plasma therapy to Covid patients if requested by their physic.Last month the Indian Council of Medical Research dropped the plasma therapy as Covid-19 treatment, citing no significant benefit.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Lok Sabha Election 2024

Heatwave In India

Mumbai Water Cut

Maharashtra Lok Sabha Election

IPL 2024

Salman Khan

University's School Of MedicineFOLLOW

University's school of medicine, Latest News

Cricket :24 players from UAE to be added in ILT20, featuring 84 internationals from 22 ICC Full Associate member countries

Dubai, Aug 25 The inaugural roster of the UAE's International League T20 (ILT20) has 84 International players, 72 ... ...

Business :Start your medical studies in India without NEET; applications are still open for St. George’s University (SGU) in association with the Ramaiah Group of Institutions

St. George’s University August 18: In association with the Ramaiah Group of Institutions, St. George’s University, Grenada, has announced ... ...

Health :'Good cholesterol' may protect liver: Study

New York, July 24 Researchers have identified a type of "good cholesterol" that protects the liver by blocking ... ...

Cricket :World T20 will be low-scoring as pitches would be worn out: Boucher

St George's (Grenada) South African cricket team coach Mark Boucher feels the ICC T20 World Cup in October-November this ... ...

Health :Plasma therapy boosts survival in Covid patients with blood cancers

New York, June 18 Administering convalescent plasma from recovered Covid-19 patients can dramatically improve likelihood of survival among ... ...